Phibro Animal Health | PAHC - Fremdkapital





Fremdkapital Veränderung Datum
Align Technology USD 0 0 2024-12
ANI Pharmaceuticals USD 291.84M 5.84M 2025-12
Assertio Holdings USD 39.17M 120K 2025-09
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Henry Schein USD 2.31B 157M 2025-12
Idexx Laboratories USD 374.84M 17K 2025-12
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Merck USD 39.97B 6B 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Pacira USD 372.19M 4.53M 2025-12
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Zoetis USD 9.04B 1.97B 2025-12